Optimization of Synthesis of Modified mRNA
Author:
Yoo Jimeen,Zangi Lior
Reference31 articles.
1. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang NY, Tsao CW, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S (2021) Heart disease and stroke Statistics-2021 update: a report from the American Heart Association. Circulation 143(8):e254–e743. https://doi.org/10.1161/CIR.0000000000000950 2. Kaur K, Hadas Y, Kurian AA, Zak MM, Yoo J, Mahmood A, Girard H, Komargodski R, Io T, Santini MP, Sultana N, Sharkar MTK, Magadum A, Fargnoli A, Yoon S, Chepurko E, Chepurko V, Eliyahu E, Pinto D, Lebeche D, Kovacic JC, Hajjar RJ, Rafii S, Zangi L (2021) Direct reprogramming induces vascular regeneration post muscle ischemic injury. Mol Ther 29(10):3042–3058. https://doi.org/10.1016/j.ymthe.2021.07.014 3. Magadum A, Kurian AA, Chepurko E, Sassi Y, Hajjar RJ, Zangi L (2020) Specific modified mRNA translation system. Circulation 142(25):2485–2488. https://doi.org/10.1161/CIRCULATIONAHA.120.047211 4. Magadum A, Singh N, Kurian AA, Sharkar MTK, Sultana N, Chepurko E, Kaur K, Zak MM, Hadas Y, Lebeche D, Sahoo S, Hajjar R, Zangi L (2021) Therapeutic delivery of Pip4k2c-modified mRNA attenuates cardiac hypertrophy and fibrosis in the failing heart. Adv Sci (Weinh) 8(10):2004661. https://doi.org/10.1002/advs.202004661 5. Kapeli K, Yeo GW (2012) Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: implications for neurological diseases. Front Neurosci 6:144. https://doi.org/10.3389/fnins.2012.00144
|
|